Dentsply Sirona appoints new CEO, prelim Q2 revenue beats estimates

DENTSPLY SIRONA

21/07/2025 13:40

Overview

Dentsply Sirona appoints Daniel Scavilla as CEO, effective August 1, 2025

Company reports preliminary Q2 2025 revenue of $935 mln, beating expectations

Adjusted EPS for Q2 2025 expected between $0.50 and $0.52

Outlook

Company reaffirms 2025 outlook from May 8 earnings release

Dentsply Sirona expects Q2 2025 net sales of $935 mln

Company anticipates Q2 2025 adjusted EPS between $0.50 and $0.52

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Preliminary revenue
Beat
$935 mln
$933.10 mln (13 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 14 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

Wall Street's median 12-month price target for DENTSPLY SIRONA Inc is $17.00, about 7.8% above its July 18 closing price of $15.68

The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 8 three months ago

Press Release: ID:nGNX8BX9zy

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)